Bioavailability: What Are Your Thoughts On Enhancing Bioavailability With Novel Technologies?

Pharma's Almanac

Biopharma’s Ascendant Supply Chain Reveals its Present Potential & Future Promise

Steve Kuehn; Cynthia A. Challener, Ph.D.; Emilie Branch

Nice Insight

Establishing Specialized CDMO Capabilities for the Production of Advanced Therapies

Oliver Technow

BIOVECTRA

Brammer Bio: Manufacturing Personalized

Mark Allen

Nice Insight

Investment Recovery for Pharma Equipment – Part 1

Matt Hicks

Federal Equipment Company

Innovation at the Heart of Biopharmaceutical Industry Growth

Nigel Walker

Nice Insight

Rigorous Integration in a Scalable Development and Manufacturing Enterprise to Support Continued Growth of Biopharmaceuticals

Syed T. Husain

Alcami

Process Safety Evaluations Crucial to Successful CDMO Operations

Vince Ammoscato, M.Sc.; Sean Lapekas

Ash Stevens

Scale-Down Models: An Indispensable Tool to Biopharmaceutical Process Development

John Moscariello, Ph.D.

Quality Culture Wins Over Compliance

Guy Villax

Hovione

Achieving Large-Scale Cell and Gene Therapy Manufacturing

Richard Snyder, Ph.D.; Steve Kasok

Thermo Fisher Scientific

Alcami: Connected at Every Level

Mark Allen

Nice Insight

Integrating Drug Discovery and Development to Improve Efficiency and Candidate Success

Cyrus K. Mirsaidi

Sundia

Nice Insight Pharmaceutical Equipment 2016 Annual Study

KshitiJ (TJ) Ladage

Nice Insight

A Holistic Interpretation of Commitment to Quality

Oriol Prat

Grifols

Accelerating Drug Development and Manufacturing with Engineered Enzymes

Rob Wilson, Ph.D.

Codexis

Dose and Form Matter: Future of Care Demands Optimal Drug Delivery

Kevin Haehl

Unither Pharmaceuticals

Enabling Right-First-Time Tech Transfer with Effective Scale-Down Modeling

Erich Blatter, Ph.D.

GSK Contract Manufacturing

Research Database Recommendations

Guy Tiene

Nice Insight

From Qualified to Ideal: The Importance of Partnership

Guy Tiene

Nice Insight